II
INDIVIOR INC.
Organization · CA
Hires government relations
pharmaceutical company
Who they hire
What they lobby on
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; H.R.9029/S.4942, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025; H.R.8070/S.4638, National Defense Authorization Act for Fiscal Year 2025, issues related to Naloxone.
Issues related to overdose reversal products; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process; FY2025 National Defense Authorization Act (H.R.8070), issues related to Naloxone.
Issues related to overdose reversal products; H.R.2617, Consolidated Appropriations Act, 2023 (P.L.117-328) implementation; FY2024 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, S.2624/H.R.5894; H.R.4531/S.3393, SUPPORT for Patients and Communities Reauthorization Act; H.R.4007/S.2809, Halting the Epidemic of Addiction and Loss Act of 2023; FY2025 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations process.